Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
40433 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A46120 | 20960377 | Semin Liver Dis | The role of lipid metabolism in the pathogenesis of alcoholic and nonalcoholic hepatic steatosis. | 2010 | Details |
| A46121 | 20943461 | Hepatobiliary Pancreat Dis Int | Increased susceptibility to experimental steatohepatitis induced by methionine-choline deficiency in HBs-Tg mice. | 2010 | Details |
| A46122 | 20919931 | Antioxid Redox Signal | Chronic exposure to a high-fat diet induces hepatic steatosis, impairs nitric oxide bioavailability, and modifies the mitochondrial proteome in mice. | 2011 | Details |
| A46123 | 20890896 | Hepatology | On the mechanism of action of vitamin E for nonalcoholic steatohepatitis. | 2010 | Details |
| A46124 | 20888438 | Mitochondrion | Mitochondrial DNA does not contribute to the heritability of non-alcoholic fatty liver disease. | 2010 | Details |
| A46125 | 20880166 | J Gastroenterol Hepatol | Failure of islet β-cell compensation for insulin resistance causes type 2 diabetes: what causes non-alcoholic fatty liver disease and non-alcoholic steatohepatitis? | 2010 | Details |
| A46126 | 20879883 | N Engl J Med | Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease. | 2010 | Details |
| A46127 | 28839567 | Frontline Gastroenterol | Non-alcoholic fatty liver disease: a non-problem or public health catastrophe? | 2010 | Details |
| A46128 | 20879029 | Hepatology | Patatin-like phospholipase domain-containing 3 and the pathogenesis and progression of pediatric nonalcoholic fatty liver disease. | 2010 | Details |
| A46129 | 20863537 | Metabolism | Serum uric acid levels predict incident nonalcoholic fatty liver disease in healthy Korean men. | 2010 | Details |
| A46130 | 20860563 | Liver Int | Cross-regulation of cannabinoid CB₁ and CB₂ receptors governs hepatic steatosis. | 2010 | Details |
| A46131 | 20849438 | Liver Int | Clinical interpretation of Fibroscan® results: a real challenge. | 2010 | Details |
| A46132 | 20846208 | Int J Clin Pract | Non-alcoholic fatty liver disease and pharmacological options. | 2010 | Details |
| A46133 | 20827721 | Hepatology | Liver enzymes, nonalcoholic fatty liver disease, and incident cardiovascular disease. | 2010 | Details |
| A46134 | 20822767 | Am J Obstet Gynecol | Maternal high-fat intake predisposes nonalcoholic fatty liver disease in C57BL/6 offspring. | 2010 | Details |
| A46135 | 20817302 | J Hepatol | Nonalcoholic fatty liver disease: the hepatic trigger of the metabolic syndrome. | 2010 | Details |
| A46136 | 20814895 | Hepatology | Fructose at the center of necroinflammation and fibrosis in nonalcoholic steatohepatitis. | 2010 | Details |
| A46137 | 20812353 | Hepatology | Emerging genes associated with the progression of nonalcoholic fatty liver disease. | 2010 | Details |
| A46138 | 20808243 | J Pediatr Gastroenterol Nutr | Biomarkers in nonalcoholic fatty liver disease: a new era in diagnosis and staging of disease in children. | 2010 | Details |
| A46139 | 20807839 | Am J Physiol Endocrinol Metab | A high-fat, ketogenic diet causes hepatic insulin resistance in mice, despite increasing energy expenditure and preventing weight gain. | 2010 | Details |
| A46140 | 20800308 | J Hepatol | Fibroblast growth factor 21 as a biomarker for NAFLD: integrating pathobiology into clinical practice. | 2010 | Details |
| A46141 | 20799351 | Hepatology | Liver-specific suppressor of cytokine signaling-3 deletion in mice enhances hepatic insulin sensitivity and lipogenesis resulting in fatty liver and obesity. | 2010 | Details |
| A46142 | 20798858 | J Obes | Long-term effects of metformin and lifestyle modification on nonalcoholic Fatty liver disease obese adolescents. | 2010 | Details |
| A46143 | 20739088 | J Hepatol | Dissecting the evolutionary genetics of iron overload in non-alcoholic fatty liver disease. | 2010 | Details |
| A46144 | 20731092 | Voen Med Zh | [Condition of the intestinal tract microbiocenosis in patients with nonalcoholic fatty liver disease and the methods of its correction]. | 2010 | Details |
| A46145 | 20726032 | Hepatology | Hypouricemic therapy: a novel potential therapeutic option for nonalcoholic fatty liver disease. | 2010 | Details |
| A46146 | 20725907 | Hepatology | Nonalcoholic fatty liver in a developing country is responsible for significant liver disease. | 2010 | Details |
| A46147 | 20724529 | Am J Physiol Gastrointest Liver Physiol | Betaine improves nonalcoholic fatty liver and associated hepatic insulin resistance: a potential mechanism for hepatoprotection by betaine. | 2010 | Details |
| A46148 | 20721462 | Arq Gastroenterol | Evaluation of the nonalcoholic fat liver disease fibrosis score for patients undergoing bariatric surgery. | 2010 | Details |
| A46149 | 20717042 | J Clin Gastroenterol | The potential adverse role of leptin resistance in nonalcoholic fatty liver disease: a hypothesis based on critical review of the literature. | 2011 | Details |
| A46150 | 20714438 | Int J Med Sci | Predictors of hepatic steatosis in HBeAg-negative chronic hepatitis B patients and their diagnostic values in hepatic fibrosis. | 2010 | Details |
| A46151 | 20710138 | South Med J | Nonalcoholic steatohepatitis: a review of the literature and updates in management. | 2010 | Details |
| A46152 | 20698076 | Zhonghua Gan Zang Bing Za Zhi | Guidelines for management of nonalcoholic fatty liver disease: an updated and revised edition. | 2010 | Details |
| A46153 | 20683979 | Hepatology | Is cigarette smoking an independent risk factor or a cofactor for nonalcoholic fatty liver disease? | 2010 | Details |
| A46154 | 20683940 | Hepatology | New insights into the role of iron in the development of nonalcoholic fatty liver disease. | 2010 | Details |
| A46155 | 20675238 | Pediatr Neonatol | Risk factors for liver steatosis in obese children and adolescents. | 2010 | Details |
| A46156 | 20959244 | Rev Gastroenterol Mex | [Liver diseases. Non-alcoholic fatty liver disease]. | 2010 | Details |
| A46157 | 20672381 | Hepatology | Suggestion of a dual-functional agent for future trials in nonalcoholic fatty liver disease. | 2010 | Details |
| A46158 | 20665947 | Eur J Gastroenterol Hepatol | Noninvasive liver steatosis quantification using MRI techniques combined with blood markers. | 2010 | Details |
| A46159 | 20660030 | J Clin Endocrinol Metab | Increased visceral adipocyte lipolysis--a pathogenic role in nonalcoholic fatty liver disease? | 2010 | Details |
| A46160 | 20653078 | N Engl J Med | Apolipoprotein C3 gene variants in nonalcoholic fatty liver disease. | 2010 | Details |
| A46161 | 20653077 | N Engl J Med | Apolipoprotein C3 gene variants in nonalcoholic fatty liver disease. | 2010 | Details |
| A46162 | 20650925 | Gut | Non-alcoholic fatty liver disease as a risk factor for hepatocellular carcinoma: mechanisms and implications. | 2010 | Details |
| A46163 | 20648554 | Hepatology | Patatin-like phospholipase domain-containing 3/adiponutrin deficiency in mice is not associated with fatty liver disease. | 2010 | Details |
| A46164 | 20647217 | N Engl J Med | Apolipoprotein C3 gene variants in nonalcoholic fatty liver disease. | 2010 | Details |
| A46165 | 20639500 | J Biomol Screen | Identification of MicroRNAs that control lipid droplet formation and growth in hepatocytes via high-content screening. | 2010 | Details |
| A46166 | 20636624 | Aliment Pharmacol Ther | Role of nitric oxide in the treatment of non-alcoholic fatty liver by omega-3 fatty acids. | 2010 | Details |
| A46167 | 20633523 | J Acupunct Meridian Stud | Effects of Teucrium polium on Insulin Resistance in Nonalcoholic Steatohepatitis. | 2010 | Details |
| A46168 | 20626072 | Nat Rev Gastroenterol Hepatol | Liver: Nonobese individuals in the developing world are at risk of nonalcoholic fatty liver and liver disease. | 2010 | Details |
| A46169 | 20623203 | Obes Surg | The relationship of plasma adiponectin with liver fibrosis in morbid obesity. | 2010 | Details |
| A46170 | 20616415 | Saudi J Gastroenterol | Grape seed extract to improve liver function in patients with nonalcoholic fatty liver change. | 2010 | Details |
| A46171 | 20605492 | Acad Radiol | Metabolic syndrome and ectopic fat deposition: what can CT and MR provide? | 2010 | Details |
| A46172 | 20595439 | Pediatr Rev | Nonalcoholic fatty liver disease. | 2010 | Details |
| A46173 | 20583213 | Hepatology | "Nonalcoholic fatty liver disease" in a developing country: a different perspective. | 2010 | Details |
| A46174 | 20581678 | Curr Opin Lipidol | Recent insights into fatty liver, metabolic dyslipidaemia and their links to insulin resistance. | 2010 | Details |
| A46175 | 20578155 | Hepatology | Cigarette smoking is not associated with specific histological features or severity of nonalcoholic fatty liver disease. | 2010 | Details |
| A46176 | 20567582 | Gastroenterol Hepatol (N Y) | The treatment of hepatic encephalopathy in the cirrhotic patient. | 2010 | Details |
| A46177 | 20566726 | CMAJ | Newly diagnosed diabetes mellitus as a risk factor for serious liver disease. | 2010 | Details |
| A46178 | 20561701 | J Hepatol | Non-alcoholic fatty liver disease, alcohol intake and psoriasis. | 2010 | Details |
| A46179 | 20530735 | Am J Physiol Endocrinol Metab | FATP2 is a hepatic fatty acid transporter and peroxisomal very long-chain acyl-CoA synthetase. | 2010 | Details |
| A46180 | 20521114 | Dig Dis Sci | Omega-3 fatty acids: a promising alternative treatment approach for patients with nonalcoholic fatty liver disease. | 2010 | Details |
| A46181 | 20520981 | Arq Gastroenterol | The vitamin E reduces liver lipoperoxidation and fibrosis in a model of nonalcoholic steatohepatitis. | 2010 | Details |
| A46182 | 20513013 | Hepatology | Low levels of 25-hydroxyvitamin D(3) in children with biopsy-proven nonalcoholic fatty liver disease. | 2010 | Details |
| A46183 | 20490678 | Dig Dis Sci | Metformin: a therapeutic option for treating nonalcoholic fatty liver disease. | 2010 | Details |
| A46184 | 20490434 | Braz J Med Biol Res | Beneficial effects of exercise training (treadmill) on insulin resistance and nonalcoholic fatty liver disease in high-fat fed C57BL/6 mice. | 2010 | Details |
| A46185 | 20489152 | Am J Pathol | Challenging the rodent hegemony: a new rabbit model of nonalcoholic steatohepatitis. | 2010 | Details |
| A46186 | 20470896 | Biochim Biophys Acta | Lipid-induced up-regulation of human acyl-CoA synthetase 5 promotes hepatocellular apoptosis. | 2010 | Details |
| A46187 | 20470767 | Clin Biochem | Serum glycated albumin levels, but not glycated hemoglobin, is low in relation to glycemia in non-diabetic men with nonalcoholic fatty liver disease with high alanine aminotransferase levels. | 2010 | Details |
| A46188 | 20458845 | Acta Gastroenterol Belg | Elevated serum uric acid is an independent risk factor for nonalcoholic fatty liver disease in Japanese undergoing a health checkup. | 2010 | Details |
| A46189 | 20458758 | World J Gastroenterol | Understanding mechanisms of the pathogenesis of nonalcoholic fatty liver disease. | 2010 | Details |
| A46190 | 20456035 | Liver Int | Human adenovirus-36 and non-alcoholic fatty liver disease. | 2010 | Details |
| A46191 | 20454765 | ScientificWorldJournal | Resolution of adipose tissue inflammation. | 2010 | Details |
| A46192 | 20452916 | J Am Pharm Assoc (2003) | Clarifying metformin's role and risks in liver dysfunction. | 2010 | Details |
| A46193 | 20446518 | Mo Med | Liver biopsy diagnosis of hepatitis: clues to clinically-meaningful reporting. | 2010 | Details |
| A46194 | 20446347 | Curr Opin Anaesthesiol | Metabolic syndrome: anesthesia for morbid obesity. | 2010 | Details |
| A46195 | 20427385 | Gut | Paediatric non-alcoholic fatty liver disease. | 2010 | Details |
| A46196 | 20423314 | Curr Med Chem | Pathophysiological role of pigment epithelium-derived factor (PEDF) in hepatic disorders. | 2010 | Details |
| A46197 | 20417942 | Metabolism | Microalbuminuria and nonalcoholic fatty liver disease. | 2010 | Details |
| A46198 | 20415823 | Dermatol Ther | Psoriasis, the liver, and the gastrointestinal tract. | 2010 | Details |
| A46199 | 20413144 | Hum Pathol | A comparison of the fibrotic potential of nonalcoholic fatty liver disease and chronic hepatitis C. | 2010 | Details |
| A46200 | 20402505 | J Proteome Res | Metabolomic assessment of the effect of dietary cholesterol in the progressive development of fatty liver disease. | 2010 | Details |
| A46201 | 20400906 | J Pediatr Gastroenterol Nutr | Nonalcoholic fatty liver disease in 2 siblings with adult-onset type II citrullinemia. | 2010 | Details |
| A46202 | 20391295 | Semin Thromb Hemost | Disorders of coagulation and hemostasis in abdominal obesity: emerging role of fatty liver. | 2010 | Details |
| A46203 | 20385430 | J Hepatol | Combination of acarbose and ezetimibe prevents non-alcoholic fatty liver disease: a break of intestinal insulin resistance? | 2010 | Details |
| A46204 | 20377484 | Scand J Gastroenterol | Comment and reply on: Serum chemerin and vaspin in non-alcoholic fatty liver disease. | 2010 | Details |
| A46205 | 20375212 | J Clin Endocrinol Metab | Chemerin correlates with markers for fatty liver in morbidly obese patients and strongly decreases after weight loss induced by bariatric surgery. | 2010 | Details |
| A46206 | 20373463 | Liver Transpl | Outcomes of liver transplantation in patients with cirrhosis due to nonalcoholic steatohepatitis versus patients with cirrhosis due to alcoholic liver disease. | 2010 | Details |
| A46207 | 20373452 | Liver Transpl | Recurrence of nonalcoholic fatty liver disease after liver transplantation: it is common, but does it affect outcome? | 2010 | Details |
| A46208 | 20373385 | Magn Reson Med | Independent estimation of T*2 for water and fat for improved accuracy of fat quantification. | 2010 | Details |
| A46209 | 20371660 | J Clin Endocrinol Metab | Effect of fenofibrate and niacin on intrahepatic triglyceride content, very low-density lipoprotein kinetics, and insulin action in obese subjects with nonalcoholic fatty liver disease. | 2010 | Details |
| A46210 | 20370675 | Curr Pharm Des | Adiponectin: a key player in obesity related disorders. | 2010 | Details |
| A46211 | 20360293 | Mayo Clin Proc | Statins in the treatment of dyslipidemia in the presence of elevated liver aminotransferase levels: a therapeutic dilemma. | 2010 | Details |
| A46212 | 20347746 | J Am Coll Surg | Clinical review of nonalcoholic steatohepatitis in liver surgery and transplantation. | 2010 | Details |
| A46213 | 20335584 | N Engl J Med | Apolipoprotein C3 gene variants in nonalcoholic fatty liver disease. | 2010 | Details |
| A46214 | 20304711 | Dig Liver Dis | Introduction to the Mini-Symposium on non-alcoholic fatty liver disease. | 2010 | Details |
| A46215 | 20232488 | Hepatology | Natural approach against lipotoxic traffic in nonalcoholic fatty liver disease. | 2010 | Details |
| A46216 | 20225248 | Hepatology | Glucagon-like peptide-1 receptor is present on human hepatocytes and has a direct role in decreasing hepatic steatosis in vitro by modulating elements of the insulin signaling pathway. | 2010 | Details |
| A46217 | 20222668 | J Proteome Res | Mitochondrial complex I subunits are decreased in murine nonalcoholic fatty liver disease: implication of peroxynitrite. | 2010 | Details |
| A46218 | 20222092 | Hepatology | Nonobese population in a developing country has a high prevalence of nonalcoholic fatty liver and significant liver disease. | 2010 | Details |
| A46219 | 20217240 | Mol Biol Rep | Oxidative stress induced by high-glucose diet in liver of C57BL/6J mice and its underlying mechanism. | 2010 | Details |